Management of Hot Flashes in Women with Breast Cancer

L. Kligman; J. Younus

doi:10.3747/co.v17i1.473

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 February 2010

Management of Hot Flashes in Women with Breast Cancer

and

Supportive Care, London Regional Cancer Program, London, ON N6A 4L6, Canada

Author to whom correspondence should be addressed.

Curr. Oncol.2010, 17(1), 81-86;https://doi.org/10.3747/co.v17i1.473

Version Notes

Order Reprints

Abstract

Hormone-suppression therapies are used for the treatment of breast cancer in the adjuvant and metastatic settings alike. However, side effects—including hot flashes—are frequently reported by patients as a cause of therapy discontinuation. This paper presents an overview of hormonal therapies and the evidence-based management options for hot flashes, summarized in a treatment algorithm.

Keywords:

breast cancer; hot flashes; tamoxifen; aromatase inhibitors

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Microrna Let-7: An Emerging Next-Generation Cancer Therapeutic

Management of Aromatase Inhibitor–Induced Arthralgia